Arrowhead Pharmaceuticals (ARWR) Amortization - Intangibles (2010 - 2011)
Arrowhead Pharmaceuticals' (ARWR) quarterly Amortization - Intangibles came in at $71618.0 in Q4 2011, up 18.47% YoY from $60452.0 in Q4 2010, and up 18.47% on a QoQ basis from $60452.0 in Q3 2011.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Amortization - Intangibles (2010 - 2011) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 2 years of Amortization - Intangibles data on file, last reported at $71618.0 in Q4 2011.
- Quarterly Amortization - Intangibles rose 18.47% year-over-year to $71618.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $252974.0 (changed N/A YoY) and the FY2011 annual result came in at $241808.0, changed 0.0% from the prior year.
- Amortization - Intangibles climbed to $71618.0 in Q4 2011, from $60452.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $71618.0 in Q4 2011 to a low of $60452.0 in Q2 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Arrowhead Pharmaceuticals | 12.40 Bn | 10.80 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | 71,618.00 |
| Sep 30, 2011 | 60,452.00 |
| Jun 30, 2011 | 60,452.00 |
| Dec 31, 2010 | 60,452.00 |
| Sep 30, 2010 | 60,452.00 |
| Jun 30, 2010 | 60,452.00 |